|
HU0303147D0
|
|
Pharmaceutical compositions for oral and topical administration
|
|
GB9919288D0
|
|
Pharmaceutical compositions for oral and topical administration
|
|
CZ9902150A3
|
|
Process for preparing 8{beta}-methylthiomethyl derivatives of ergoline
|
|
CZ426798A3
|
|
Therapeutical preparations for peroral and topic applications
|
|
CZ405598A3
|
|
Industrial production strain of Claviceps purpurea (Fr.) Tul. microorganism
|
|
GB9813941D0
|
|
Cyclosporin formulation
|
|
CZ57198A3
|
|
Process for preparing substituted amides of d-lysergic and d-dihydrolysergic acid and derivatives thereof
|
|
CZ314497A3
|
|
Process for preparing ergoline derivatives
|
|
CZ283516B6
|
|
Therapeutical preparations, particularly for internal administration in the form of self-micro-emulsifying therapeutic systems
|
|
CZ77894A3
|
|
INDUSTRIAL PRODUCTION STRAIN OF CLAVICEPS PURPUREA /Fr./Tul. MICRO-ORGANISM
|
|
CZ77994A3
|
|
INDUSTRIAL PRODUCTION STRAIN OF CLAVICEPS PURPUREA (Fr)Tul. MICRO-ORGANISM
|
|
SK88193A3
|
|
Method of preparing of 3,14beta-dihydroxy-17-normorphinan
|
|
CZ283392A3
|
|
6-deoxo derivatives of ergopeptides, and process for preparing thereof
|
|
CS160990A3
|
|
Process for preparing storage stable preparations with a high content of fibrous fungi germinant spores
|
